Concepts (117)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Ultrasonography, Prenatal | 3 | 2020 | 471 | 0.41 | Why? |
| Prenatal Care | 3 | 2020 | 1314 | 0.30 | Why? |
| Pregnancy Complications, Infectious | 8 | 2021 | 11559 | 0.27 | Why? |
| Labor, Induced | 2 | 2020 | 186 | 0.23 | Why? |
| Pregnancy Outcome | 3 | 2021 | 3803 | 0.20 | Why? |
| Pregnancy, High-Risk | 1 | 2020 | 128 | 0.19 | Why? |
| Labor Stage, Second | 1 | 2018 | 12 | 0.19 | Why? |
| New York City | 9 | 2021 | 7432 | 0.18 | Why? |
| Fetal Development | 2 | 2017 | 173 | 0.18 | Why? |
| Cesarean Section | 4 | 2021 | 2089 | 0.17 | Why? |
| Biometry | 1 | 2017 | 69 | 0.17 | Why? |
| Anthropometry | 1 | 2017 | 233 | 0.16 | Why? |
| Pregnancy | 15 | 2021 | 23879 | 0.15 | Why? |
| Carrier State | 3 | 2021 | 2100 | 0.13 | Why? |
| Perinatal Care | 1 | 2020 | 576 | 0.13 | Why? |
| Patient Safety | 2 | 2020 | 4885 | 0.13 | Why? |
| Fetus | 1 | 2017 | 484 | 0.13 | Why? |
| Gestational Age | 4 | 2020 | 1488 | 0.13 | Why? |
| Pregnancy Complications | 2 | 2020 | 1388 | 0.11 | Why? |
| Premature Birth | 3 | 2020 | 2151 | 0.11 | Why? |
| Maternal Age | 2 | 2021 | 244 | 0.09 | Why? |
| National Institute of Child Health and Human Development (U.S.) | 2 | 2017 | 24 | 0.09 | Why? |
| Fetal Organ Maturity | 1 | 2007 | 25 | 0.09 | Why? |
| Infectious Disease Transmission, Vertical | 2 | 2021 | 5164 | 0.08 | Why? |
| Respiratory Distress Syndrome, Newborn | 1 | 2007 | 124 | 0.08 | Why? |
| Telemedicine | 4 | 2020 | 25032 | 0.07 | Why? |
| Ambulatory Care | 1 | 2020 | 4947 | 0.06 | Why? |
| Oxygen Inhalation Therapy | 3 | 2020 | 3629 | 0.06 | Why? |
| Chorioamnionitis | 1 | 2021 | 50 | 0.06 | Why? |
| Asymptomatic Infections | 1 | 2020 | 7218 | 0.05 | Why? |
| Delivery, Obstetric | 2 | 2021 | 1292 | 0.05 | Why? |
| Uterine Inertia | 1 | 2020 | 13 | 0.05 | Why? |
| Nicardipine | 1 | 2020 | 13 | 0.05 | Why? |
| Bronchial Spasm | 1 | 2020 | 13 | 0.05 | Why? |
| Linear Models | 2 | 2017 | 1914 | 0.05 | Why? |
| Multi-Institutional Systems | 1 | 2020 | 97 | 0.05 | Why? |
| Mass Screening | 1 | 2020 | 8005 | 0.05 | Why? |
| Pregnancy in Diabetics | 1 | 2020 | 56 | 0.05 | Why? |
| Tachypnea | 1 | 2020 | 197 | 0.05 | Why? |
| Enzyme Inhibitors | 2 | 2020 | 1881 | 0.05 | Why? |
| Obstetric Labor, Premature | 1 | 2020 | 114 | 0.05 | Why? |
| Fever | 3 | 2021 | 7795 | 0.05 | Why? |
| Postpartum Hemorrhage | 1 | 2020 | 144 | 0.05 | Why? |
| Evaluation Studies as Topic | 1 | 2020 | 391 | 0.05 | Why? |
| New Jersey | 1 | 2020 | 528 | 0.05 | Why? |
| Transitional Care | 1 | 2020 | 135 | 0.05 | Why? |
| Parity | 1 | 2018 | 122 | 0.04 | Why? |
| Ceftriaxone | 1 | 2020 | 365 | 0.04 | Why? |
| Genetic Counseling | 1 | 2020 | 229 | 0.04 | Why? |
| Prenatal Diagnosis | 1 | 2020 | 345 | 0.04 | Why? |
| Asymptomatic Diseases | 2 | 2020 | 3444 | 0.04 | Why? |
| Cervix Uteri | 1 | 2018 | 146 | 0.04 | Why? |
| Labor, Obstetric | 1 | 2020 | 257 | 0.04 | Why? |
| Female | 15 | 2021 | 380317 | 0.04 | Why? |
| Pregnancy Complications, Cardiovascular | 1 | 2020 | 231 | 0.04 | Why? |
| Obstetrics and Gynecology Department, Hospital | 1 | 2020 | 241 | 0.04 | Why? |
| Infection Control | 3 | 2020 | 23131 | 0.04 | Why? |
| Dyspnea | 2 | 2020 | 3847 | 0.04 | Why? |
| Critical Illness | 1 | 2020 | 17281 | 0.04 | Why? |
| Birth Weight | 1 | 2017 | 250 | 0.04 | Why? |
| Hospitals, Community | 1 | 2020 | 475 | 0.04 | Why? |
| Hypoxia | 2 | 2020 | 3626 | 0.04 | Why? |
| Anesthesia, General | 1 | 2020 | 470 | 0.04 | Why? |
| Medicaid | 1 | 2020 | 492 | 0.04 | Why? |
| Fluid Therapy | 1 | 2020 | 628 | 0.04 | Why? |
| Infant, Newborn | 4 | 2021 | 23105 | 0.04 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.04 | Why? |
| Azithromycin | 2 | 2020 | 3943 | 0.04 | Why? |
| Hospitalization | 3 | 2021 | 54280 | 0.04 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.03 | Why? |
| Myalgia | 1 | 2020 | 1015 | 0.03 | Why? |
| Delivery of Health Care | 1 | 2020 | 15909 | 0.03 | Why? |
| Adult | 9 | 2021 | 244371 | 0.03 | Why? |
| Health Personnel | 2 | 2020 | 29646 | 0.03 | Why? |
| New York | 1 | 2020 | 2488 | 0.03 | Why? |
| Weight Gain | 1 | 2017 | 552 | 0.03 | Why? |
| Young Adult | 5 | 2021 | 93724 | 0.03 | Why? |
| Retrospective Studies | 5 | 2021 | 105322 | 0.03 | Why? |
| Cohort Studies | 3 | 2021 | 36005 | 0.03 | Why? |
| Pandemics | 5 | 2020 | 389249 | 0.03 | Why? |
| Residence Characteristics | 1 | 2021 | 1927 | 0.03 | Why? |
| Humans | 15 | 2021 | 930598 | 0.02 | Why? |
| Adrenal Cortex Hormones | 1 | 2007 | 6537 | 0.02 | Why? |
| Intensive Care Units | 3 | 2020 | 29594 | 0.02 | Why? |
| Anti-Bacterial Agents | 2 | 2020 | 10083 | 0.02 | Why? |
| Qualitative Research | 1 | 2020 | 4337 | 0.02 | Why? |
| Academic Medical Centers | 1 | 2020 | 3088 | 0.02 | Why? |
| Antihypertensive Agents | 1 | 2020 | 1962 | 0.02 | Why? |
| Hospitals, University | 1 | 2020 | 4173 | 0.02 | Why? |
| Electronic Health Records | 1 | 2020 | 3492 | 0.02 | Why? |
| United States | 3 | 2020 | 46150 | 0.02 | Why? |
| Risk Factors | 3 | 2021 | 71621 | 0.02 | Why? |
| Cough | 1 | 2020 | 4891 | 0.02 | Why? |
| Hydroxychloroquine | 2 | 2020 | 12447 | 0.02 | Why? |
| Logistic Models | 1 | 2021 | 9089 | 0.02 | Why? |
| Comorbidity | 2 | 2020 | 34796 | 0.02 | Why? |
| Remote Consultation | 1 | 2020 | 2396 | 0.02 | Why? |
| Body Mass Index | 1 | 2017 | 4306 | 0.02 | Why? |
| Intubation, Intratracheal | 1 | 2020 | 3962 | 0.02 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.02 | Why? |
| Length of Stay | 1 | 2021 | 11042 | 0.02 | Why? |
| Health Status Disparities | 1 | 2020 | 4072 | 0.02 | Why? |
| Prospective Studies | 2 | 2017 | 43301 | 0.01 | Why? |
| Severity of Illness Index | 2 | 2020 | 48226 | 0.01 | Why? |
| Attitude of Health Personnel | 1 | 2020 | 4741 | 0.01 | Why? |
| Disease Management | 1 | 2020 | 6841 | 0.01 | Why? |
| Occupational Exposure | 1 | 2020 | 4742 | 0.01 | Why? |
| Pneumonia | 1 | 2021 | 5652 | 0.01 | Why? |
| Acute Kidney Injury | 1 | 2020 | 5762 | 0.01 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2020 | 6166 | 0.01 | Why? |
| Hypertension | 1 | 2020 | 8895 | 0.01 | Why? |
| Lung | 1 | 2007 | 31049 | 0.01 | Why? |
| Obesity | 1 | 2017 | 7388 | 0.01 | Why? |
| Health Services Accessibility | 1 | 2020 | 10697 | 0.01 | Why? |
| Time Factors | 1 | 2018 | 31397 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2020 | 22116 | 0.01 | Why? |
| Male | 3 | 2021 | 367725 | 0.01 | Why? |
Fuchs's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(117)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(79)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_